DEDaniel E. SpeiserJun 27, 2025New paperautoPaperEngineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancerScience Advances · 2025 · Margaux Saillard, Mara Cenerenti, Patrick Reichenbach et al.1